NOVELIX logo

Novelix Pharmaceuticals Ltd

NOVELIX·BSE·
76.50 -3.00 (-3.77%)
Market Cap226.34 Cr
PE Ratio956.25
Volume1,912
Day High - Low79.89 - 76.12
52W High-Low92.00 - 49.01
DocStoX Score
2.6/10
Poor
Fair Value
Sign in to see
ROE
8.00%
Weak
P/E
956.25x
Expensive
Debt / Equity
0.09
Low
Industry
Retail
Pharmacy Retail
Overall View
Mixed

Price performance

Day76.12
79.89
52W49.01
92.00
DocStoX take

Supported by growth (9.0) and momentum (7.0), but held back by valuation (0.0). Growth looks strong at 9.0, but that is offset by valuation at 0.0 and quality at 0.3. We are calling it Mixed rather than resolving the conflict for you.

DocStoX score

Low confidence
2.6
/10
Poor
Quality
Weak
ROE 8.0%
Valuation
Expensive
P/E 200.0×
Growth
Strong
Revenue +55.9% 5Y CAGR
Risk
Elevated
D/E 0.09
Momentum
Firm
64% of 52-week range

At a glance

Market Cap
₹226 Cr
52W High / Low
₹92 / ₹49
Dividend Yield
0.00%
Promoter Holding
54.29%
EPS (TTM)
₹0.08
Book Value
₹23.08

Key highlights

  • Revenue compounding 56% a year
  • Low leverage — D/E 0.09
  • Loss-making in some of the last 5 years
  • Quality is weak (0.3/10)
2 Positives4 Watchouts

Growth

Financials

Shareholding

Technicals

Peers

News

Forecasts

About the company

More data

Filings, corporate actions and ownership detail — opened on demand.

More Retail stocks · Pharmacy Retail

Novelix Pharmaceuticals Ltd peers in Retail

Other Retail stocks on the NSE & BSE. See the full Retail sector list.